AN2 Therapeutics, Inc.'s total assets for Q4 2024 were $92.09M, a decrease of -5.73% from the previous quarter. ANTX total liabilities were $10.24M for the fiscal quarter, a 2.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.